Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | MCM2 |
| Upstream (Parents) |
|---|
| (<<) KIF2C → MCM2 |
| (<<) MCM10 → MCM2 |
| (<<) C1orf63 → MCM2 |
| (<<) SPEN → MCM2 |
| (<<) TPX2 → MCM2 |
| (<<) KIF4A → MCM2 |
| Downstream (Children) |
|---|
| MCM2 → EXO1 (>>) |
| MCM2 → OIP5 (>>) |
| MCM2 → INSIG1 (>>) |
| MCM2 → PPP1R7 (>>) |
| MCM2 → DPP3 (>>) |
| MCM2 → KIF2C (>>) |
| MCM2 → POLD1 (>>) |
| MCM2 → NME2///NME1 (>>) |
| MCM2 → CYP4F8 (>>) |
| MCM2 → PSD3 (>>) |
| MCM2 → MCM10 (>>) |
| MCM2 → AASS (>>) |
| MCM2 → NR4A2 (>>) |
| MCM2 → AGBL3 (>>) |
| MCM2 → FADS2 (>>) |
| MCM2 → STOM (>>) |
| MCM2 → RAPGEF3 (>>) |
| MCM2 → CDC6 (>>) |
| MCM2 → MYBL2 (>>) |
| MCM2 → MBNL3 (>>) |
| MCM2 → SEMA6A (>>) |
| MCM2 → LPPR3 (>>) |
| MCM2 → CCNA2 (>>) |
| MCM2 → C6orf155 (>>) |
| MCM2 → TDO2 (>>) |
| MCM2 → HMGB3 (>>) |
| MCM2 → C1orf106 (>>) |
| MCM2 → N4BP2L2 (>>) |
| MCM2 → TPX2 (>>) |
| MCM2 → TK1 (>>) |
| MCM2 → SFRP5 (>>) |
| MCM2 → CTSL2 (>>) |
| MCM2 → EVL (>>) |
| MCM2 → NEIL3 (>>) |
| MCM2 → GINS1 (>>) |
| MCM2 → KIF4A (>>) |
| MCM2 → FAM64A (>>) |
| MCM2 → TMEM97 (>>) |
